Pharmetheus at ASCPT
We will be attending ASCPT 2026 in Denver, March 4–6. Visit our poster session or join our MIDD session to discuss the latest in Model-Informed Drug Development.
Scientific contributions
In this Lunch & learn event, Martin Bergstrand and Emma Hansson will provide insights into the evolving application of MIDD in regulatory settings.
Presenter: Henrik Bjurgård Nyberg
Poster session II
Thursday March 5, 2026
5:00 PM – 7:00 PM
Rewarded Top Poster Ribbon.
This recognition highlights the research team’s innovative work, collaborative spirit, and impact of advancing new approaches to bioequivalence.
Access to generic drugs is a key driver for global pharmacoequity. However, for complex products such as long-acting injectables (LAIs) and highly variable drugs (HVDs), traditional bioequivalence (BE) methods based on non-compartmental analysis (NCA) can be impractical or require prohibitively large sample sizes.
By leveraging MBBE to tackle these challenges, our team is advancing practical, science-driven solutions to streamline drug development and lower barriers to market entry.
Authors: Henrik Bjugård Nyberg, Andrew Hooker, Martin Bergstrand, Marylore Chenel, and Niclas Jonsson.
